Mouse Hepatic Oval Cells

Cat.No.: CSC-C5368S

Species: Mouse

Source: Liver

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C5368S
Description
Hepatic oval cells are a type of stem cells in the liver with strong proliferative capacity and differentiation potential. During severe acute injury to the liver, hepatic oval cells are activated and can differentiate into a variety of functional cells such as hepatic parenchymal cells and intrahepatic bile duct epithelial cells to repair the liver injury. Hepatic oval cells have both intrahepatic and extrahepatic sources. In addition, hepatic oval cells are also closely related to the development of primary hepatocellular carcinoma.
Mouse hepatic oval cells from Creative Bioarray are isolated from the mouse liver tissue. The method we use to isolate mouse hepatic oval cells was developed based on a combination of established and our proprietary methods. The mouse hepatic oval cells are characterized by immunofluorescence with antibodies specific to receptor tyrosine kinase (c-Kit) or alpha fetoprotein (AFP). Each vial contains 0.5x10^6 cells per ml and is delivered frozen.
Species
Mouse
Source
Liver
Recommended Medium
SuperCult® Mouse Hepatic Oval Cell Medium
Disease
Normal
Quality Control
Mouse Hepatic Oval Cells are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Never can cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Mouse Hepatic Oval Cells (MHOCs) are bipotential liver progenitor cells isolated from the liver of mice, typically after chronic liver injury or 2/3 partial hepatectomy. These cells serve as an important tool for the study of liver regeneration, hepatic differentiation, and mechanisms of liver disease in vitro because they have the capacity to differentiate into hepatocytes and biliary epithelial cells (cholangiocytes).

MHOCs are small epithelial-like cells that generally proliferate as an adherent monolayer with the ability to cluster into colony-forming masses. They express progenitor cell markers such as A6, EpCAM, CK19 and differentiate to express hepatic markers including alpha-fetoprotein (AFP) and albumin. MHOCs retain responsiveness to growth factors and cytokines such as HGF, EGF and TGF-β important for regulating proliferation, differentiation and survival.

Due to their bipotential differentiation capacity MHOCs are commonly used to study liver regeneration, fibrosis/hepatocarcinogenesis, and cholangiopathies. They have been used as a tool to study mechanisms regulating activation of stem/progenitor cells after chronic liver injury including factors regulating proliferation and migration, signaling pathways important for specification into different cell lineages, drug toxicity testing, and many applications involving gene editing and disease modeling in vitro.

A timeline representing the stages of oval cell activation: activation, proliferation, migration, and differentiation.

Fig. 1. A timeline representing the stages of oval cell activation: activation, proliferation, migration, and differentiation (Erker L and Grompe M, 2008).

HOCs Morphological Features in the Original Generation and Differentiation into BDEs

Hepatic oval cells (HOCs) can differentiate into cholangiocytes during liver regeneration, but the epigenetic mechanisms governing this transition remain unclear. Jin's team investigated whether histone methyltransferase SETD2 and its product H3K36me3 regulate HOC-to-cholangiocyte differentiation following partial hepatectomy and 2-acetamidofluorene exposure in mice.

A modified two-step enzyme digestion method established hepatic oval cell (HOC) proliferation in a mouse 2-AAF/PH model. Isolated HOCs were small, oval cells with high nuclear/cytoplasmic ratios (Fig. 1A). After 3 days in cytokine-containing medium, first-generation colonies showed rapid growth with gradually enlarging nuclei (Fig. 1B, C). By passages 2-3, cells became irregular-shaped with large volume and prominent nuclei (Fig. 1D, E). Passages 4-5 showed bile duct epithelial (BDE) differentiation with enlarged cell mass and volume (Fig. 1F, G). Passages 6-8 exhibited bile duct epithelium changes with pseudopodia-like growth and three-dimensional structure without bottom layering (Fig. 1H-J).

They investigated SETD2/H3K36me3 expression changes during HOC differentiation into BDEs. Although SETD2/H3K36me3 roles in cell differentiation are established in other stem cells, their dynamics in this process were previously unexplored. HOCs were induced to differentiate into BDEs using EGF (20 µg/l) + SCF (10 µg/l) + LIF (10 µg/l). Passages 5 and 8, distinguishable by morphology, were selected for analysis. Immunofluorescence showed SETD2 expressed in both nucleus and cytoplasm with significant increase from primary generation onward, while H3K36me3 was mainly nuclear and gradually increased during differentiation (Fig. 2Aa-d, Ba-d). Confocal microscopy of passage 3 BDEs confirmed SETD2 in nucleus/cytoplasm and H3K36me3 predominantly nuclear (Fig. 2Ca, b). RT-qPCR revealed SETD2 mRNA gradually increased and stabilized during differentiation (Fig. 2D). Western blotting showed SETD2 and H3K36me3 protein levels increased ~35% in passage 3 BDEs versus primary HOCs, and ~75% in passages 5 and 8 mature BDEs, thereafter stabilizing (Fig. 2E, F).

HOCs morphological features in the original generation and differentiation into BDEs with 10 µg EGF + 5 µg stem cell growth factor + 5 µg leukemia inhibitory factor.

Fig. 1. HOCs morphological features in the original generation and differentiation into BDEs with 10 µg EGF + 5 µg stem cell growth factor + 5 µg leukemia inhibitory factor (Jin L, Su Z, et al., 2023).

SETD2 and H3K36me3 expression in mice HOCs induced to differentiate into BDEs in vitro.

Fig. 2. SETD2 and H3K36me3 expression in mice HOCs induced to differentiate into BDEs in vitro (Jin L, Su Z, et al., 2023).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products